Baron Silver Stevens Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$302K Sell
835
-2
-0.2% -$685 0.04% 116
2026
Q1
$294K Hold
837
0.04% 109
2025
Q4
$274K Sell
837
-90
-10% -$28.5K 0.04% 108
2025
Q3
$262K Hold
927
0.04% 121
2025
Q2
$259K Buy
927
+90
+11% +$25.5K 0.04% 113
2025
Q1
$261K Buy
837
+3
+0.4% +$886 0.05% 99
2024
Q4
$217K Buy
834
+79
+10% +$23.4K 0.04% 118
2024
Q3
$243K Buy
755
+78
+12% +$25.5K 0.04% 106
2024
Q2
$212K Sell
677
-97
-13% -$28.5K 0.04% 108
2024
Q1
$220K Buy
+774
New +$226K 0.04% 114
2021
Q1
Sell
-197
Closed -$45K 67
2020
Q4
$45K Buy
+197
New +$45.4K 0.02% 144

Other funds holding AMGN

Baron Silver Stevens Financial Advisors's AMGN Position: Q2 2026 in Review

Baron Silver Stevens Financial Advisors reduced its Amgen (AMGN) stake by 0.24% in Q2 2026, selling an estimated $685 and leaving 835 shares worth $302K. The position accounts for 0.04% of the portfolio, ranked #116.

Baron Silver Stevens Financial Advisors first reported a position in AMGN in Q4 2020 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Baron Silver Stevens Financial Advisors held 835 shares of Amgen worth $302K as of Q2 2026.
  • Baron Silver Stevens Financial Advisors sold 2 Amgen shares in Q2 2026, an estimated $685.
  • Amgen made up 0.04% of Baron Silver Stevens Financial Advisors's portfolio in Q2 2026, its #116 holding.
  • Baron Silver Stevens Financial Advisors first reported a position in Amgen in Q4 2020 and has held it in 11 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Baron Silver Stevens Financial Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.